CLINICAL_TRIALS
trial_result
· 2023-03-27
Clinical Trial Update: Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis [Phase 3]
Summary
Phase 3 randomized placebo-controlled study of ISA247 in plaque psoriasis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2023-03-27